explore -WSS

explore

author：Wikipedia 2025-08-12 06:44:50 - browse：7759

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Humana’s losses in Medicare Advantage tank its stock

WSS

How artificial intelligence is being used to detect, treat cancer

White House launches permanent pandemic office

Zyn nicotine pouches become unlikely player in latest culture war

How generative AI ratchets up security threats for health systems

New clues to why women have higher risk of autoimmune disorders

Artificial intelligence advances fuel industry trying to preserve loved ones after death

knowledge

explore

knowledge

The high cost of giving birth even with insurance

Merck, Johnson & Johnson CEOs will testify on high drug prices

ChatGPT in medicine: STAT answers readers' burning questions

Medicare Advantage insurers face 0.2% cut to 2025 payments

Jerome Adams on the need for new antivirals for Covid

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Continuity nursing helped my family in our darkest PICU moments

Why an extreme heat and wildfire smoke combination can be so dangerous

Affirmative action in medical school literally saved lives

FTC sues over Novant Health acquisition of two N.C. hospitals

leisure time

Bernie Sanders is gearing up to subpoena pharma CEOs

How generative AI ratchets up security threats for health systems

Why an extreme heat and wildfire smoke combination can be so dangerous

CDC backtracks, saying fully vaccinated people can go maskless indoors

Artificial intelligence advances fuel industry trying to preserve loved ones after death

HIPAA doesn't protect reproductive records from prosecutors

focus

entertainment

focus

hotspot